stocksKIMS
KIMS

Krishna Institute of Medical Sciences Ltd

Sector: Healthcare
Industry Group: Healthcare Services
Industry: Hospital
846.45+8.5 (+1.02%)
3 Jul, 9:59 AM

Income Statement

Abridged
Understanding Income Statement
Krishna Institute of Medical Sciences Ltd income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
2013
Mar 31
2014
Mar 31
2015
Mar 31
2016
Mar 31
2017
Mar 31
2018
Mar 31
2019
Mar 31
2020
Mar 31
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
PR
12M
PR
12M
PR
12M
PR
12M
PR
12M
PR
12M
PR
12M
PR
12M
PR
12M
AR
12M
AR
12M
AR
12M
AR
12M
PRESS
Total Revenue
2943514205125676649181,1231,3301,6512,1982,4983,0353,905
Cost of Operating Revenue
1792122522883163635026116627741,1301,3041,5741,092
Gross Profit
1141391682242513014165126688771,0671,1941,4612,813
Gross Margin
38.939.640.043.744.345.345.445.650.253.148.647.848.172.0
Total Operating Expenses
2543113744404865688069471,0281,2051,7232,0042,4263,386
Operating Profit
394045728196112176302446475494609519
Operating Margin
13.411.310.814.114.214.412.215.622.727.021.619.820.113.3
Financing Income/(Expense) - Net
-15-28-32-34-30-83-45-39-27-4-21-42-77-203
Profit before Taxes
2815144153-20-15141279457485460558334
Income Taxes
1010713192633257411311912414392
Profit after Tax
19662733-47-48119201333336310385241
PAT Margin
6.51.61.35.25.7-7.1-5.210.615.120.215.312.412.76.2
EPS - Basic - ex Extraordinary Items
0.470.140.140.670.81-1.18-1.192.985.038.388.417.759.616.03
EPS - Diluted - ex Extraordinary Items
0.470.140.140.670.81-1.18-1.192.985.038.388.417.759.616.03
EBIT
394045728196112176302446475494609519
EBITDA
606577108116136168246372519604640786802
EBITDA Margin
20.518.418.521.020.420.518.321.928.031.427.525.625.920.5

Balance Sheet

Abridged
Understanding Balance Sheet
Krishna Institute of Medical Sciences Ltd balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
2013
Mar 31
2014
Mar 31
2015
Mar 31
2016
Mar 31
2017
Mar 31
2018
Mar 31
2019
Mar 31
2020
Mar 31
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Source:
PR
PR
PR
PR
PR
PR
PR
PR
PR
AR
AR
AR
AR
PRESS
Total Current Assets
6398101115156156174220451393478547697937
Long-Term Investments
209111411031675178
Property Plant & Equipment - Net
4835185205155807097648078319091,8582,6614,1565,921
Total Non-Current Assets
5045395575516198029469769851,5142,4643,3055,0396,821
Total Assets
5666376576667759581,1201,1961,4361,9072,9413,8525,7367,759
Total Current Liabilities
1881931701741917492012192782152964528361,239
Long Term Debt
1602042011741972942883142282266341,2262,2873,637
Total Non-Current Liabilities
1862422432222503473523662822827071,3062,4453,961
Total Liabilities
3744354133964411,0965535845604971,0031,7593,2825,200
Total Shareholders' Equity
192196238263326-1585415988641,3871,6701,8282,1742,247
Minority Interest
056772026131223268265281311
Total Equity
192202244270334-1385676118761,4111,9382,0932,4552,559
Total Liabilities & Equity
5666376576667759581,1201,1961,4361,9072,9413,8525,7367,759

Cash Flow

Abridged
Understanding Cash Flow Statement
Krishna Institute of Medical Sciences Ltd cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
2013
Mar 31
2014
Mar 31
2015
Mar 31
2016
Mar 31
2017
Mar 31
2018
Mar 31
2019
Mar 31
2020
Mar 31
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
PR
12M
PR
12M
PR
12M
PR
12M
PR
12M
PR
12M
PR
12M
PR
12M
PR
12M
AR
12M
AR
12M
AR
12M
AR
12M
PRESS
Operating CF bef Changes in Working Cap
463035777781136169318399493447517458
Working Capital - Increase/(Decrease)
-2117-4-17-26-2-28014-74-6915-77-151
Net CF from Operating Activities
244630605178108170332324424463440307
Capital Expenditures - Net
85568135100577751941705726469621,413
Net CF from Investing Activities
-82-66-73-41-101-64-110-126-358-424-626-754-1,124-1,461
Stock - Issuance/(Retirement) - Net
--37-31-88-95192----
Debt - LT & ST - Issuance/(Retirement) - Total
582211-2924-12-89-11-58-1191074577811,261
Net Cash Flow from Financing Activities
582248-3055-12-1-1137731072766931,153
Free Cash Flow to Equity
-313-40-3-2510-5810718135-41274259155
Free Operating CF net dividend
-61-22-5526-492031118238154-151-184-569-1,121
Free Operating CF
-61-22-5526-492031118238154-151-184-569-1,121

Business Segment Analysis

FY End:
Mar 25

Krishna Institute of Medical Sciences Ltd business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex
Total₹ 1,009Cr
Medical and healthcare services (100.0%)₹ 1,008.90 Cr
Revenue / Sales
Total₹ 3,035Cr
Medical and healthcare services (100.0%)₹ 3,035.10 Cr
Assets
Total₹ 5,736Cr
Medical and healthcare services (100.0%)₹ 5,736.00 Cr
Operating Income
Total₹ 609Cr
Medical and healthcare services (100.0%)₹ 608.70 Cr

Regional Segment Analysis

FY End:
Mar 25

Krishna Institute of Medical Sciences Ltd geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales
Total₹ 3,035Cr
India (100.0%)₹ 3,035.10 Cr
Assets
Total₹ 5,736Cr
India (100.0%)₹ 5,736.00 Cr

Historical Segment Analysis

Track how Krishna Institute of Medical Sciences Ltd segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Business
2013
Mar 31
2014
Mar 31
2017
Mar 31
2018
Mar 31
2019
Mar 31
2020
Mar 31
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
Medical and healthcare services13059100597752941705756471,009
Electricity sales00---------

Frequently Asked Questions

What is the revenue of Krishna Institute of Medical Sciences Ltd?
The latest trailing twelve month revenue of Krishna Institute of Medical Sciences Ltd is ₹ 3,904.60 Cr, reflecting a 1-year growth of 28.65% and a 3-year CAGR of 21.12%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Krishna Institute of Medical Sciences Ltd?
The latest trailing twelve month net profit (PAT) of Krishna Institute of Medical Sciences Ltd is ₹ 241.40 Cr, with a 3-year earnings CAGR of -10.48%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Krishna Institute of Medical Sciences Ltd?
The trailing twelve month EBITDA of Krishna Institute of Medical Sciences Ltd is approximately ₹ 518.80 Cr (based on an operating margin of 13.29%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Krishna Institute of Medical Sciences Ltd?
The trailing twelve month Earnings Per Share (EPS) of Krishna Institute of Medical Sciences Ltd is 6.03. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Krishna Institute of Medical Sciences Ltd?
The debt-to-equity ratio of Krishna Institute of Medical Sciences Ltd stands at 1.89. The interest coverage ratio is 2.56x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Krishna Institute of Medical Sciences Ltd?
The estimated book value per share of Krishna Institute of Medical Sciences Ltd is 54.05 (derived from a P/B ratio of 15.66 and market price of ₹ 846.45), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Krishna Institute of Medical Sciences Ltd?
The trailing twelve month operating cash flow of Krishna Institute of Medical Sciences Ltd is ₹ 307.40 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Krishna Institute of Medical Sciences Ltd report consolidated or standalone financials?
Krishna Institute of Medical Sciences Ltd reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.